Foreign-Trade Zone 7-Mayaguez, Puerto Rico, Application for Subzone, MOVA Pharmaceutical Corporation (Pharmaceutical Manufacturing), Manatí, Puerto Rico, 49255-49256 [E7-17036]

Download as PDF Federal Register / Vol. 72, No. 166 / Tuesday, August 28, 2007 / Notices agents of BEA without prior written permission of the person filing the report. By law, each employee as well as each agent is subject to a jail term of up to 5 years, a fine of up to $250,000, or both for disclosing to the public any identifiable information that is reported about a business or institution. Section 515 of the Information Quality Guidelines applies to this survey. The collection and use of this information complies with all applicable information quality guidelines, i.e., those of the Office of Management and Budget, Department of Commerce, and BEA. III. Method of Collection A survey with a cover letter that includes a brief description of, and rationale for, the survey will be sent by e-mail to potential respondents by the first week of June of each year. A report of the respondent’s expenditures of the NIH award amounts, following the proposed format for expenditure categories included with the survey’s cover letter, will be requested to be completed and submitted online no later than 60 days after mailing. Survey respondents will be selected on the basis of award levels, which determine the weight of the respondent in the biomedical research and development price index. Potential respondents will include (1) the top 100 organizations in total awards, which account for about 74 percent of total awards; (2) 40 additional organizations that are not primarily in the ‘‘Research and Development (R&D) contracts’’ category; and (3) 10 additional organizations that are primarily in the ‘‘R&D contracts’’ category. IV. Data OMB Number: 0608–0069. Form Number: None. Type of Review: Regular submission. Affected Public: Universities or other organizations that are NIH award recipients. Estimated Number of Respondents: 90. Estimated Time per Response: 11 hours and 12 minutes. Estimated Total Annual Burden Hours: 1,008. Estimated Total Annual Cost: $41,610. pwalker on PROD1PC71 with NOTICES V. Request for Comments Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the NIH, including whether the information has practical utility: (b) the accuracy of the agency’s estimate of the burden (including hours VerDate Aug<31>2005 19:52 Aug 27, 2007 Jkt 211001 and cost) of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and/or included in the request for OMB approval of this information collection; They also will become a matter of public record. Dated: August 22, 2007. Gwellnar Banks, Management Analyst, Office of the Chief Information Officer. [FR Doc. E7–16965 Filed 8–27–07; 8:45 am] BILLING CODE 3510–EA–P DEPARTMENT OF COMMERCE Foreign–Trade Zones Board [Docket 38–2007] Foreign–Trade Zone 7—Mayaguez, Puerto Rico, Application for Subzone, MOVA Pharmaceutical Corporation (Pharmaceutical Manufacturing), ´ Manatı, Puerto Rico An application has been submitted to the Foreign–Trade Zones (FTZ) Board (the Board) by the Puerto Rico Industrial Development Company, grantee of FTZ 7, requesting special–purpose subzone status with manufacturing authority for pharmaceutical products at the pharmaceutical manufacturing facility of MOVA Pharmaceutical Corporation (MOVA), located in Manat´, Puerto Rico. The application was submitted pursuant to the Foreign–Trade Zones Act, as amended (19 U.S.C. 81a–81u), and the regulations of the Board (15 CFR part 400). It was formally filed on August 14, 2007. The proposed subzone facility (104 acres, 17 buildings totaling 410, 000 sq. ft., 40 percent of which is devoted to manufacturing) is located at State Road 670, Km 2.7 in Manat´, Puerto Rico. The company has indicated that the square footage of the buildings devoted to manufacturing operations could increase to include up to 70 percent of the total in the near future. The MOVA facility (310 employees) has requested authority to manufacture two pharmaceutical products, Januvia/ MK–431A (HTSUS 3004.90) and sitagliptin (HTSUS 2933.59), on behalf of Merck, Sharpe & Dohme Quimica de Puerto Rico, Inc. Duty rates on the finished products range from duty–free PO 00000 Frm 00009 Fmt 4703 Sfmt 4703 49255 to 6.5 percent, ad valorem. Foreign– origin material inputs to be used in the manufacturing process (up to 25 percent of total materials, by value) include sitagliptin (HTSUS 2933.59), metformin hydrochloride (HTSUS 2925.20), enamine amide (HTSUS 2933.59), and butyl josphos (HTSUS 2931.00), which have duty rates of 3.7 percent to 6.5 percent, ad valorem. The application also requests authority to include a broad range of inputs and finished pharmaceutical products that MOVA may produce under FTZ procedures in the future. (As required by the Board’s regulations, new major activity involving these inputs/ products would require review by the Board.) The duty rates for these inputs and final products range from duty–free to 10 percent. FTZ procedures would exempt MOVA from customs duty payments on foreign materials used in export production to non–NAFTA countries. Some 30 to 40 percent of the plant’s shipments are exported. On its domestic shipments and sales to NAFTA countries, MOVA could defer duty until the products are entered for consumption or exported, and choose the lower duty rate that applies to the finished product for the foreign components used in production. The company may also realize certain logistical/procedural savings related to zone–to zone transfers and direct delivery procedures as well as savings on materials that become scrap/waste during manufacturing. The application indicates that FTZ procedures would help improve the plant’s international competitiveness. In accordance with the Board’s regulations, a member of the FTZ staff has been designated examiner to investigate the application and report to the Board. Public comment is invited from interested parties. Submissions (original and 3 copies) shall be addressed to the Board’s Executive Secretary at the address below. The closing period for their receipt is October 29, 2007. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period (to November 13, 2007). A copy of the application will be available for public inspection at each of the following locations: U.S. Department of Commerce Export Assistance Center, Centro Internacional de Mercado, Tower II, Suite 702, Road 165, Guaynabo, Puerto Rico, 00968– 8058; and, Office of the Executive Secretary, Foreign–Trade Zones Board, Room 2111, U.S. Department of E:\FR\FM\28AUN1.SGM 28AUN1 49256 Federal Register / Vol. 72, No. 166 / Tuesday, August 28, 2007 / Notices Commerce, 1401 Constitution Avenue, NW, Washington, D.C. 20230–0002. For further information, contact Diane Finver at DianelFinver@ita.doc.gov or (202) 482–1367. Dated: August 21, 2007. Andrew McGilvray, Executive Secretary. [FR Doc. E7–17036 Filed 8–27–07; 8:45 am] BILLING CODE 3510–DS–S DEPARTMENT OF COMMERCE Bureau of Industry and Security Proposed Information Collection; Comment Request; Technical Data Letter of Explanation Bureau of Industry and Security (BIS), Department of Commerce. ACTION: Notice. AGENCY: SUMMARY: The Department of Commerce, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. DATES: Written comments must be submitted on or before October 29, 2007. Direct all written comments to Diana Hynek, Departmental Paperwork Clearance Officer, Department of Commerce, Room 6625, 14th and Constitution Avenue, NW., Washington, DC 20230 (or via the Internet at dHynek@doc.gov). FOR FURTHER INFORMATION CONTACT: Requests for additional information or copies of the information collection instrument and instructions should be directed to Larry Hall, BIS ICB Liaison, (202) 482–4896, lhall@bis.doc.gov. SUPPLEMENTARY INFORMATION: ADDRESSES: I. Abstract pwalker on PROD1PC71 with NOTICES These technical data letters of explanation will assure BIS that U.S.origin technical data will be exported only for authorized end-uses, users and destinations. The letters also place the foreign consignee on notice that the technical data is subject to U.S. export controls and may only be reexported in accordance with U.S. law. II. Method of Collection Submitted on paper or electronically. III. Data OMB Control Number: 0694–0047. VerDate Aug<31>2005 19:52 Aug 27, 2007 Jkt 211001 Form Number(s): None. Type of Review: Business or for-profit organizations. Estimated Number of Respondents: 5,050. Estimated Time per Response: 30 minutes to 2 hours. Estimated Total Annual Burden Hours: 8,807. Estimated Total Annual Cost to Public: $0. IV. Request for Comments Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden (including hours and cost) of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and/or included in the request for OMB approval of this information collection; they also will become a matter of public record. Dated: August 22, 2007. Gwellnar Banks, Management Analyst, Office of the Chief Information Officer. [FR Doc. E7–16973 Filed 8–27–07; 8:45 am] BILLING CODE 3510–DT–P DEPARTMENT OF COMMERCE International Trade Administration Export Trade Certificate of Review Notice of Modification of Export Trade Certificate of Review Application No. 92–00015. ACTION: SUMMARY: The Secretary of Commerce issued an Export Trade Certificate of Review to Refined Sugar Trading Institute on May 3, 1993. Because this Certificate Holder has failed to file a complete annual report as required by law, the Secretary is modifying the certificate. This notice summarizes the notification letter sent to Refined Sugar Trading Institute. FOR FURTHER INFORMATION CONTACT: Jeffrey Anspacher, Director, Export Trading Company Affairs, International Trade Administration, 202/482–5131. This is not a Toll-free number. PO 00000 Frm 00010 Fmt 4703 Sfmt 4703 Title III of the Export Trading Company Act of 1982 (‘‘The Act’’) (Pub. L. 97–290, 15 U.S.C. 4011–21) Authorizes the Secretary of Commerce to Issue Export Trade Certificates of Review. The Regulations Implementing Title III (‘‘the Regulations’’) are found at 15 CFR Part 325 (1999). Pursuant to this Authority, a Certificate of Review was issued on May 3, 1993 to Refined Sugar Trading Institute. A Certificate Holder is required by law to submit to the Secretary of Commerce Annual Reports that update financial and other information relating to business activities covered by its Certificate (Section 308 of the Act, 15 U.S.C. 4018, Section 325.14(a) of the Regulations, 15 CFR 325.14(a)). The Annual Report is due within 45 days after the Anniversary Date of the Issuance of the Certificate of Review (Sections 325.14(a) and (b) of the Regulations). Failure to submit a complete Annual Report may be the Basis for Modification or Revocation (Sections 325.10(a)(3) and 325.14(c) of the Regulations). On the following dates April 23, 2005, April 23, 2006 and April 23, 2007, the Secretary of Commerce sent to Refined Sugar Trading Institute a letter containing Annual Report questions stating that its annual report was due on June 17, 2005, June 17, 2006 and June 17, 2007, respectively. The Secretary has received no written response from Refined Sugar Trading Institute or Domino Sugar Corporation relating to Domino Sugar Corporation’s annual report. On July 12, 2007, and in accordance with Section 325.14(a) and (b) of the Regulations, the Secretary of Commerce sent a letter by Certified Mail to notify Refined Sugar Trading Institute that the Secretary was formally initiating the process to modify its Certificate to remove Domino Sugar Corporation for its failure to file annual reports directly or through the Refined Sugar Trading Institute. The Secretary has received no response from Refined Sugar Trading Institute. Pursuant to Section 325.10(a)(3) of the Regulations (15 CFR 325.10(a)(3)), the Secretary considers the response of Refined Sugar Trading Institute to be an admission of the statements contained in the notification letter. The Secretary has determined to modify the Certificate issued to Refined Sugar Trading Institute for the failure to file a complete Annual Report. The Secretary has sent a letter, dated August 20, 2007 to notify the Refined Sugar Trading Institute of its final determination. The Modification is effective thirty (30) days from the date of publication of this notice (325.10(a)(3) of the SUPPLEMENTARY INFORMATION: E:\FR\FM\28AUN1.SGM 28AUN1

Agencies

[Federal Register Volume 72, Number 166 (Tuesday, August 28, 2007)]
[Notices]
[Pages 49255-49256]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-17036]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Docket 38-2007]


Foreign-Trade Zone 7--Mayaguez, Puerto Rico, Application for 
Subzone, MOVA Pharmaceutical Corporation (Pharmaceutical 
Manufacturing), Manat[iacute], Puerto Rico

    An application has been submitted to the Foreign-Trade Zones (FTZ) 
Board (the Board) by the Puerto Rico Industrial Development Company, 
grantee of FTZ 7, requesting special-purpose subzone status with 
manufacturing authority for pharmaceutical products at the 
pharmaceutical manufacturing facility of MOVA Pharmaceutical 
Corporation (MOVA), located in Manat[acute], Puerto Rico. The 
application was submitted pursuant to the Foreign-Trade Zones Act, as 
amended (19 U.S.C. 81a-81u), and the regulations of the Board (15 CFR 
part 400). It was formally filed on August 14, 2007.
    The proposed subzone facility (104 acres, 17 buildings totaling 
410, 000 sq. ft., 40 percent of which is devoted to manufacturing) is 
located at State Road 670, Km 2.7 in Manat[acute], Puerto Rico. The 
company has indicated that the square footage of the buildings devoted 
to manufacturing operations could increase to include up to 70 percent 
of the total in the near future.
    The MOVA facility (310 employees) has requested authority to 
manufacture two pharmaceutical products, Januvia/MK-431A (HTSUS 
3004.90) and sitagliptin (HTSUS 2933.59), on behalf of Merck, Sharpe & 
Dohme Quimica de Puerto Rico, Inc. Duty rates on the finished products 
range from duty-free to 6.5 percent, ad valorem. Foreign-origin 
material inputs to be used in the manufacturing process (up to 25 
percent of total materials, by value) include sitagliptin (HTSUS 
2933.59), metformin hydrochloride (HTSUS 2925.20), enamine amide (HTSUS 
2933.59), and butyl josphos (HTSUS 2931.00), which have duty rates of 
3.7 percent to 6.5 percent, ad valorem.
    The application also requests authority to include a broad range of 
inputs and finished pharmaceutical products that MOVA may produce under 
FTZ procedures in the future. (As required by the Board's regulations, 
new major activity involving these inputs/products would require review 
by the Board.) The duty rates for these inputs and final products range 
from duty-free to 10 percent.
    FTZ procedures would exempt MOVA from customs duty payments on 
foreign materials used in export production to non-NAFTA countries. 
Some 30 to 40 percent of the plant's shipments are exported. On its 
domestic shipments and sales to NAFTA countries, MOVA could defer duty 
until the products are entered for consumption or exported, and choose 
the lower duty rate that applies to the finished product for the 
foreign components used in production. The company may also realize 
certain logistical/procedural savings related to zone-to zone transfers 
and direct delivery procedures as well as savings on materials that 
become scrap/waste during manufacturing. The application indicates that 
FTZ procedures would help improve the plant's international 
competitiveness.
    In accordance with the Board's regulations, a member of the FTZ 
staff has been designated examiner to investigate the application and 
report to the Board.
    Public comment is invited from interested parties. Submissions 
(original and 3 copies) shall be addressed to the Board's Executive 
Secretary at the address below. The closing period for their receipt is 
October 29, 2007. Rebuttal comments in response to material submitted 
during the foregoing period may be submitted during the subsequent 15-
day period (to November 13, 2007).
    A copy of the application will be available for public inspection 
at each of the following locations: U.S. Department of Commerce Export 
Assistance Center, Centro Internacional de Mercado, Tower II, Suite 
702, Road 165, Guaynabo, Puerto Rico, 00968-8058; and, Office of the 
Executive Secretary, Foreign-Trade Zones Board, Room 2111, U.S. 
Department of

[[Page 49256]]

Commerce, 1401 Constitution Avenue, NW, Washington, D.C. 20230-0002.
    For further information, contact Diane Finver at Diane--
Finver@ita.doc.gov or (202) 482-1367.

    Dated: August 21, 2007.
Andrew McGilvray,
Executive Secretary.
[FR Doc. E7-17036 Filed 8-27-07; 8:45 am]
BILLING CODE 3510-DS-S

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.